GLOBAL BIOENERGIES delivers an isobutene test sample to CLARIANT

EVRY, France, June 27, 2016 (GLOBE NEWSWIRE) -- Global Bioenergies (Alternext Paris: ALGBE) announces having delivered isobutene produced at its industrial pilot to Clariant, a leading specialty chemical company.

Clariant is a Swiss stock-market listed company with revenues exceeding 5 billion euros in 2015, active in a variety of chemical markets such as specialty polymers.

Global Bioenergies' most advanced program consists in the production of high-purity isobutene from renewable resources. A sample of such renewable isobutene, produced at the company's industrial pilot plant, has been shipped to Clariant, where tests regarding Clariant's application of interest have been carried out successfully.

Thomas Buhl, Head of Business Development at Global Bioenergies comments: "After Cristal Union, Audi, Arkema, CFBP, Arlanxeo and L'Oréal, we are pleased to add a seventh company to our list of major industrialists interested in our technology. Clariant is known for developing innovative solutions towards a more environment-friendly chemistry, a mission shared by Global Bioenergies."

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, builds its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).

Should you like to be kept informed, subscribe to our news feed on www.global-bioenergies.com

Follow us on Twitter: @GlobalBioenergi

Contact

GLOBAL BIOENERGIES Thomas BUHL Head of Business Development Phone:                 +33 (0)1 64 98 20 50 Email: [email protected]

Press release http://hugin.info/166909/R/2023313/751756.pdf

HUG#2023313

You May Also Be Interested In

• Perimeter Announces Preliminary Second Quarter 2026 Financial Results
• Lucky Strike Entertainment to Report Fourth Quarter and Full Year 2026 Financial Results on August 27, 2026
• Advance ER Physicians Join Bubble Lounge Podcast to Help Park Cities Families Get Ready for Back-to-School and Cold & Flu Season